To compare discrete event simulation (DES) models with Markov models for simulating patient flows in an intensive care unit (ICU). METHODS: We developed a Markov model and a DES model to simulate the patient flow in an ICU with a focus on mechanical ventilation (MV) on the basis of the Dutch UltiSAFE trial. In UltiSAFE, different sedation regimens (remifentanil-based sedation vs. conventional sedation) in critically ill patients requiring mechanical ventilation were investigated. We defined 8 states in the models: MV-maintenance, MV-eligible for weaning, MV-actual weaning, MV-eligible for extubation, ICU-extubated, ICU-eligible for discharge, Discharged from ICU, and Dead. Patients move through states 1 to 7 in sequence, unless they die. In the Markov model, a time cycle of 1 hour was applied. We compared the models with respect to results (length of stay in each phase), ease of scenario analysis, stability of results and computation time.
MO2 INCORPORATING CALIBRATED MODEL PARAMETERS INTO SENSITIVITY ANALYSES: DETERMINISTIC AND PROBABILISTIC APPROACHES
To examine new methods of incorporating model calibration into sensitivity analyses and the effect of calibration choices on the robustness of model results and uncertainty of model parameters. METHODS: Seventy-nine model transition probabilities used to describe the natural history of cervical cancer (CC) were calibrated to thirty published target epidemiologic data using Nelder-Mead optimization. Because factors such as choice of objective function (goodness-of-fit measure) and initial simplex (starting point) may lead to different optimized solutions, we tested the effect of these choices by performing fifteen calibrations using five different objective function weighting schemes and three different initial simplexes. The objective function was weighted mean percentage deviation calculated by dividing the absolute value of the difference between model estimate and target value by the target value. Deterministic sensitivity analyses (DSA) were performed by inserting each of the fifteen calibrated parameter sets into the model and assessing the results. In probabilistic sensitivity analyses (PSA), we assigned an equal probability of selection to each calibrated parameter set and bootstrapped (sampled with replacement) the calibrated parameter sets, combining them with a conventional second-order Monte Carlo simulation for other model parameters. Model results were assessed using a cost per quality-adjusted life-year (QALY) incremental cost-effectiveness ratio (ICER). RESULTS: The coefficient of variation of individual transition probabilities across the fifteen calibrated parameter sets ranged from 0.06%-162%. In DSA, the ICER range produced by the calibrations was $6,700-$27,100 per QALY. When bootstrapped calibrations were included in the PSA, the ICER 95% credible interval was [$6,400,$28 ,000] compared with [$1,100,$9,400] when using only the best-fitting calibration. CONCLUSIONS: Different calibration methods can lead to different optimized parameter sets, producing different model results. Model calibration should therefore be incorporated into sensitivity analyses to fully assess the effects of calibration methods on model results.
MO3 COMPARING METHODS OF DATA SYNTHESIS: UPDATING PARAMETERS OF AN EXISTING PROBABILISTIC COST-EFFECTIVENESS MODEL
Oppe M, Al MJ, Rutten-van Mölken MP Erasmus MC, Rotterdam, The Netherlands OBJECTIVES: Cost-effectiveness models should always be amendable to updating once new data become available. However, no one optimal method of synthesizing data currently exists. METHODS: We compared three different methods to pool existing parameters of a model for a chronic disease with new data: fixed effects (FE) and random effects (RE) meta-analysis and Bayesian updating (BU). These methods were applied to obtain updated estimates of transition probabilities between stable disease states and event probabilities. RESULTS: Homogeneity between studies providing "old" and "new" information was confirmed using the Q-statistic. The three methods resulted in different estimates of probabilities and their standard errors (SE). The FE model produced the lowest means and SEs for the event probabilities (moderate disease: 0.0496 (0.0028); severe disease: 0.0698(0.0026); very severe disease: 0.0892(0.0044)) and the probabilities of the event being severe (0.1009 (0.0194); 0.1032(0.0122); 0.1761(0.0206), respectively). It also produced the lowest mean and SEs for transition probabilities. The RE model resulted in the highest probabilities of getting an event: at most 20% higher than FE in very severe disease. Furthermore, the RE model resulted in the highest SEs. The SE of the probability of getting an event was at most 276% higher than in the FE model. The SE of the probability of the event being severe was at most 112% higher. The SE for the transition probabilities was at most 218% higher than in the FE model. BU resulted in the highest probability of an event being severe: up to 20% higher than FE in the case of moderate disease. BU resulted in the highest transition probabilities: up to 29% higher than FE. CONCLUSIONS: As shown, the choice of method can affect resulting model parameter updates considerably. This can affect estimates of costeffectiveness and the uncertainty around them.
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